Invention Grant
- Patent Title: Iminosulfanone compound as bromodomain protein inhibitor and pharmaceutical composition and medical use thereof
-
Application No.: US17262053Application Date: 2019-07-25
-
Publication No.: US12030880B2Publication Date: 2024-07-09
- Inventor: Jijun Li , Yan Zhu , Yeliu Wang , Xianxing Shang , Huting Wang , Weinan He , Qin Yan , Yinghui Sun , Kai Zhang , Chang Lu , Hongjiang Xu , Xin Tian , Ling Yang
- Applicant: CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. , SHOUYAO HOLDINGS (BEIJING) CO., LTD. , LIANYUNGANG RUNZHONG PHARMACEUTICAL CO., LTD.
- Applicant Address: CN Lianyungang
- Assignee: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.,Shouyao Holdings (Beijing) Co., Ltd.,Lianyungang Runzhong Pharmaceutical Co., Ltd.
- Current Assignee: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.,Shouyao Holdings (Beijing) Co., Ltd.,Lianyungang Runzhong Pharmaceutical Co., Ltd.
- Current Assignee Address: CN Lianyungang; CN Beijing; CN Lianyungang
- Agency: NIXON PEABODY LLP
- Priority: CN 1810825047.X 2018.07.25 CN 1910410273.6 2019.05.17
- International Application: PCT/CN2019/097692 2019.07.25
- International Announcement: WO2020/020288A 2020.01.30
- Date entered country: 2021-01-21
- Main IPC: C07D471/04
- IPC: C07D471/04 ; A61P35/02
Abstract:
The present invention relates to a iminosulfanone compound represented by formula (I) as a bromodomain protein inhibitor and a pharmaceutically acceptable salt thereof and to a preparation method, pharmaceutical composition, and medical use thereof.
Public/Granted literature
Information query
